首页> 美国卫生研究院文献>Clinical Molecular Pathology >Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes.
【2h】

Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes.

机译:恶性和非恶性淋巴结中的端粒酶活性和原位端粒酶RNA表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIMS/BACKGROUND: Telomerase, an enzyme associated with cellular immortality, is expressed by most malignant tumours, but is inactive in normal somatic cells except for male germ cells and proliferating stem cells. Thus, the measurement of telomerase activity in tissue samples may provide useful diagnostic and prognostic information. The aim of this study was to determine whether telomerase expression is useful for the detection of occult malignant cells in lymph nodes. METHODS: Telomerase activity was compared with histological findings in 123 surgically removed lymph nodes submitted for routine or frozen section diagnosis. Telomerase activity was measured using a modified, semi-quantitative PCR-based telomeric repeat amplification protocol (TRAP). The assay was adapted for single 5 microns OCT embedded cryostat sections. In either fresh tissues or cryostat sections, normalised activity was linear when compared with protein concentration. Furthermore, using an in situ hybridisation method, the human telomerase RNA (hTR) component was measured in a subset of negative and positive nodes. RESULTS: Most (96%) of the 97 histologically negative nodes expressed low levels of activity (mean value of positive samples = 3.0 units/microgram protein) which may be derived from activated lymphocytes that express telomerase activity. All 26 malignant nodes (17 metastases, nine lymphomas) expressed telomerase (mean value = 17.8 units/microgram protein). The rank order levels between the two groups differed significantly (p = 0.0002). In situ results showed clearly that the hTR was expressed relatively highly in metastatic cancer cells and at lower levels in germinal centres of secondary follicles. CONCLUSIONS: Although expression of telomerase by activated lymphocytes may limit its usefulness, measurement of enzyme activity combined with detection of hTR using in situ hybridisation may assist in the histopathological diagnosis of lymph nodes.
机译:目的/背景:端粒酶是一种与细胞永生有关的酶,在大多数恶性肿瘤中都有表达,但在正常的体细胞中没有活性,除了雄性生殖细胞和增殖性干细胞。因此,组织样品中端粒酶活性的测量可提供有用的诊断和预后信息。这项研究的目的是确定端粒酶表达是否可用于检测淋巴结中隐匿性恶性细胞。方法:将123例手术切除的淋巴结常规或冷冻切片诊断的端粒酶活性与组织学结果进行比较。使用改良的基于半定量PCR的端粒重复扩增方案(TRAP)测量端粒酶活性。该测定适用于单个5微米OCT嵌入式低温恒温器切片。在新鲜组织或低温恒温器切片中,与蛋白质浓度相比,标准化活性是线性的。此外,使用原位杂交方法,在阴性和阳性节点的子集中测量了人类端粒酶RNA(hTR)成分。结果:97个组织学阴性的淋巴结中的大多数(96%)表达的活性水平较低(阳性样品的均值= 3.0单位/微克蛋白质),可能来自表达端粒酶活性的活化淋巴细胞。所有26个恶性淋巴结(17个转移,9个淋巴瘤)均表达端粒酶(平均值= 17.8单位/微克蛋白质)。两组之间的排名顺序差异显着(p = 0.0002)。原位结果清楚地表明,hTR在转移性癌细胞中相对较高地表达,而在次级卵泡的生发中心则较低。结论:尽管活化的淋巴细胞表达端粒酶可能会限制其有用性,但酶活性的测定结合原位杂交检测hTR可能有助于淋巴结的组织病理学诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号